NYSEMKT:DXR

Daxor Corp Stock Predictions

NYSE American > Healthcare > Medical Instruments & Supplies

Open Broker Account

$9.65

+0 (+0%)

At Close: Apr 26, 2024

Currently predicting for Mon, 29 Apr 2024

Trading levels for DXR

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	9.65	.
		R2	9.65	.
		R1	9.65	.
Current price:			9.65
	Support	S1	9.65	.
		S2	9.65	.
		S3	9.65	.

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	9.94	3.00 %
		R2	9.75	1.04 %
		R1	9.74	0.93 %
Current price			9.65
	Support	S1	9.57	-0.83%
		S2	8.75	-9.33%
		S3	8.50	-11.92%

DXR Predictions History

1 year ago
JS predicted that DXR for 2022-06-27 is going $12.90 (-2.35%)

1 year ago
ngbots predicted that DXR for 2022-06-27 is going

4 years ago
NameNotImportant predicted that DXR for 2019-05-06 is going $8.72 (-20.04%)

5 years ago
Andy.Kirkwood.96939 predicted that DXR for 2019-02-19 is going $18.85 (5.60%)

Rank:

5 years ago
JS predicted that DXR for 2019-01-14 is going $12.57 (-3.31%)

About Daxor Corp

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation... DXR Profile

Golden Star

Ticker	Date	Change	Price
MLI	Apr 19	10.86%	$52.28
LPLA	Apr 19	0.743%	$262.59
DOOR	Apr 18	0.160%	$131.39
LNG	Apr 17	0.389%	$156.81
FCN	Apr 16	2.95%	$207.62
ELV	Apr 16	5.28%	$506.97
DXC	Apr 08	0.767%	$20.87
AKR	Apr 05	5.63%	$16.53
ITCI	Apr 05	6.84%	$68.44
SARK	Mar 28	13.80%	$26.88

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In